$11.57
1.95% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US53635D2027
Symbol
LQDA
Sector
Industry

Liquidia Technologies, Inc. Stock price

$11.57
-0.05 0.39% 1M
-0.81 6.54% 6M
-0.46 3.82% YTD
-0.62 5.09% 1Y
+6.99 152.62% 3Y
+6.63 134.21% 5Y
+0.47 4.23% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.23 1.95%
ISIN
US53635D2027
Symbol
LQDA
Sector
Industry

Key metrics

Market capitalization $979.25m
Enterprise Value $777.57m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 49.81
P/S ratio (TTM) P/S ratio 62.73
P/B ratio (TTM) P/B ratio 8.85
Revenue growth (TTM) Revenue growth -14.78%
Revenue (TTM) Revenue $15.61m
EBIT (operating result TTM) EBIT $-111.62m
Free Cash Flow (TTM) Free Cash Flow $-92.46m
Cash position $204.37m
EPS (TTM) EPS $-1.62
P/E forward negative
P/S forward 62.24
EV/Sales forward 49.42
Short interest 18.88%
Show more

Is Liquidia Technologies, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Liquidia Technologies, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Liquidia Technologies, Inc. forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a Liquidia Technologies, Inc. forecast:

Buy
91%
Hold
9%

Financial data from Liquidia Technologies, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
16 16
15% 15%
100%
- Direct Costs 6.68 6.68
61% 61%
43%
8.94 8.94
37% 37%
57%
- Selling and Administrative Expenses 75 75
142% 142%
482%
- Research and Development Expense 43 43
27% 27%
276%
-109 -109
115% 115%
-701%
- Depreciation and Amortization 2.26 2.26
14% 14%
14%
EBIT (Operating Income) EBIT -112 -112
109% 109%
-715%
Net Profit -119 -119
107% 107%
-765%

In millions USD.

Don't miss a Thing! We will send you all news about Liquidia Technologies, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Liquidia Technologies, Inc. Stock News

Positive
Seeking Alpha
about one month ago
Liquidia's Yutrepia, a competitor to United Therapeutics' Tyvaso, faces potential market entry in 2025, with promising clinical data and a competitive therapeutic profile. Despite financial challenges and intense competition, Liquidia's low valuation and upcoming product launches present a compelling investment opportunity. Liquidia's legal battles with United Therapeutics are nearing resolutio...
Neutral
Seeking Alpha
about 2 months ago
Liquidia Corporation (NASDAQ:LQDA ) Q3 2024 Earnings Conference Call November 13, 2024 8:30 AM ET Company Participants Jason Adair - Chief Business Officer Roger Jeffs - Chief Executive Officer Rusty Schundler - General Counsel Rajeev Saggar - Chief Medical Officer Michael Kaseta - Chief Operating Officer & Chief Financial Officer Scott Moomaw - Chief Commercial Officer Conference Call Particip...
Neutral
GlobeNewsWire
about 2 months ago
Received tentative approval from the FDA for YUTREPIA™ (treprostinil) inhalation powder for both pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD) U.S. Supreme Court rejected final appeal of ‘793 patent decision, marking victories with respect to three patents originally asserted final and not subject to further appeal Strengthen...
More Liquidia Technologies, Inc. News

Company Profile

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.

Head office United States
CEO Roger Jeffs
Employees 136
Founded 2004
Website www.liquidia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today